Marksans Pharma announces voluntary recall of one batch of Metformin XR tablets

Marksans Pharma Limited has issued voluntary recall of one batch of Metformin Extended Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004) due to detection of NOMA as a matter of abundant precaution.

Metformin Extended Release Tablets USP500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

Shares of MARKSANS PHARMA LTD. was last trading in BSE at Rs.31.8 as compared to the previous close of Rs. 30.3. The total number of shares traded during the day was 62159 in over 133 trades.

The stock hit an intraday high of Rs. 31.8 and intraday low of 31.8. The net turnover during the day was Rs. 1976656.

Source : Equity Bulls

Keywords